Page last updated: 2024-08-23

idarubicin and Buphthalmos

idarubicin has been researched along with Buphthalmos in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Alcalde-Ruiz, E; Catala-Mora, J; Chantada, GL; Croxatto, JO; Dabezies, AP; de Dávila, MTG; Dufort, G; Fandiño, AC; Kopp, K; López, JP; Ossandon, D; Parareda-Salles, A; Pérez, V; Ravindranath, Y; Reaman, G; Rey, G; Sampor, C; Suñol, M; Urbieta, M; Zelter, M	1

Other Studies

1 other study(ies) available for idarubicin and Buphthalmos

Article	Year
Treatment of Nonmetastatic Unilateral Retinoblastoma in Children. JAMA ophthalmology, 2018, 07-01, Volume: 136, Issue:7 Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Cyclophosphamide; Disease-Free Survival; Etoposide; Eye Enucleation; Female; Humans; Hydrophthalmos; Idarubicin; Infant; Male; Mesna; Neoplasm Metastasis; Neoplasm Staging; Prospective Studies; Retinal Neoplasms; Retinoblastoma; Survival Rate; Vincristine	2018

Article

Year

Treatment of Nonmetastatic Unilateral Retinoblastoma in Children.

JAMA ophthalmology, 2018, 07-01, Volume: 136, Issue:7

Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Cyclophosphamide; Disease-Free Survival; Etoposide; Eye Enucleation; Female; Humans; Hydrophthalmos; Idarubicin; Infant; Male; Mesna; Neoplasm Metastasis; Neoplasm Staging; Prospective Studies; Retinal Neoplasms; Retinoblastoma; Survival Rate; Vincristine

2018